Skip to content

Fighting to Preserve the Benefits of the 340B Program

Facebook page opens in new windowX page opens in new windowLinkedin page opens in new windowMail page opens in new window
RWC-340B
Ryan White Clinics for 340B Access
RWC-340B
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles
Search:
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles

waste paper gcbfb8becf 1920

United Therapeutics Seeks Records from HRSA Regarding Covered Entity Compliance with Duplicate Discount and Diversion Prohibitions

Drug Pricing, HHS, HRSA, NewsBy Andrea JeriaOctober 11, 2021

The law firm representing United Therapeutics (UT), Latham & Watkins, has filed a request with HRSA to obtain a wide range of records related to HRSA’s enforcement of the 340B…

auction g4dc206f29 1920

Sanofi Files Emergency Motion to Halt ADR Proceedings

Drug Pricing, NewsBy Andrea JeriaOctober 8, 2021

On October 7, Sanofi filed a request to the D.C. District Court to temporarily halt any 340B ADR proceedings filed against it.  Sanofi filed the request in its lawsuit challenging…

north ge08ff2fe4 1280

North Carolina PBM Reform Law Protects Certain 340B Covered Entity Types

Drug Pricing, News, RulingsBy Andrea JeriaOctober 8, 2021

On September 20, North Carolina enacted a PBM reform law, Session Law 2021-161, that includes provisions protecting certain categories of 340B covered entities against discriminatory practices.  The law protects federally…

pexels ekaterina bolovtsova 6077447

PhRMA Sues in Federal Court to Stop Enforcement of Arkansas Law

Drug Pricing, NewsBy Andrea JeriaOctober 1, 2021

On September 29, PhRMA brought a case in the U.S. District Court for the Eastern District of Arkansas to stay enforcement of the Arkansas law (Act 1103) that makes it…

financial gf32557403 1920

Senator Braun (R-IN) Introduces Legislation to Authorize HHS to Audit 340B Income

Congress, Drug Pricing, HHS, HRSA, News, RegulationsBy Andrea JeriaSeptember 27, 2021

On September 23, U.S. Senator Mike Braun (R-IN) introduced a bill to amend the 340B statute to allow HHS to audit 340B covered entities to determine how they use “net…

letters g29b225827 1920

HRSA Refers Six Pharmaceutical Manufacturers to HHS-Office of the Inspector General for Imposition of Civil Monetary Penalties

Drug Pricing, HHS, HRSA, NewsBy Andrea JeriaSeptember 22, 2021

Earlier today, HRSA sent letters to Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi, and United Therapeutics alerting them that the agency has notified the HHS-Office of the Inspector General (OIG),…

pexels andrea piacquadio 3760067

Gilead Notifies Pharmacies of Its New PAP/MAP Policy

Drug Pricing, HIV/AIDS, NewsBy Andrea JeriaSeptember 13, 2021

Gilead recently notified pharmacies that beginning January 1, 2022, they must enter into a participation agreement in order to submit claims and receive reimbursement under Gilead’s Patient Assistance Program and…

flag 28563 1280

Arkansas Law Suspended at PhRMA’s Request

Drug Pricing, HIV/AIDS, HIV/AIDS Strategy, NewsBy Andrea JeriaAugust 16, 2021

On July 29, the Arkansas Insurance Department (“AID”) issued an order suspending for 90 days (until October 27) the enforcement of certain provisions of a recently enacted Arkansas law that…

joshua coleman AVqs0ItdMQM unsplash

Merck Restricts Purchases of 340B Drugs for 340B Hospitals Effective September 1

Drug Pricing, HIV/AIDS, NewsBy Andrea JeriaAugust 13, 2021

On August 11, Merck issued a letter announcing its policy to stop “voluntarily” providing 340B discounts to hospital covered entities on drugs dispensed at contract pharmacies unless the hospital provides…

smartphone 6386599 1920

Coverage of PrEP and Other Preventative Services Without Cost-Sharing

Congress, Drug Pricing, HHS, HIV/AIDS, News, PrEPBy Andrea JeriaJuly 27, 2021

On July 19, HHS and the Departments of Labor and Treasury took an important step to remove insurance copayment requirements as a barrier to access to HIV preexposure prophylaxis (“PrEP”)…

←123456…
7891011121314
15→
                                                                            © 2021 Ryan White Clinics for 340B Access. RWC-340B is a 501(c)(4) non-profit corporation.
Go to Top
Translate »